Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AgenTus Therapeutics was formed in 2017 as a subsidiary of Agenus Inc. to accelerate development of allogeneic adoptive cell therapies. Today we are more than 25 employees working across the U.S. and the U.K. Our expert scientists are working with world leading academic and commercial institutions to pioneer the delivery of living drugs to change lives of cancer patients. AgenTus Therapeutics is focused on the discovery, de...
AgenTus Therapeutics was formed in 2017 as a subsidiary of Agenus Inc. to accelerate development of allogeneic adoptive cell therapies. Today we are more than 25 employees working across the U.S. and the U.K. Our expert scientists are working with world leading academic and commercial institutions to pioneer the delivery of living drugs to change lives of cancer patients. AgenTus Therapeutics is focused on the discovery, development, and commercialization of breakthrough “living drugs” to advance cures for cancer patients.

List your booth number for exhibitions, ask us